Cat
Name
Size
Price
Action
BR301
Breast cancer tissue array (mostly ductal carcinoma in situ), including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her-2 and Ki-67 results), 15 cases/30 cores-BR301
each
Ask
LC817b
Lung cancer with matched lymph node metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 40 cases/80 cores, replacing LC817a-LC817b
each
Ask
UT244a
Chorionic epithelial carcinoma and normal endometrial tissue array, including pathology grade, TNM and clinical stage (AJCC 7.0), 12 cases/24 cores, replacing UT244-UT244a
each
Ask
CR243b
Cervix squamous cell carcinoma with normal adjacent cervix tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores (1.5mm), replacing CR243a-CR243b
each
Ask
BL805b
Mid-advanced stage bladder cancer tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BL805a-BL805b
each
Ask
LC483a
Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th version), 48 cases/48 cores, replacing LC483-LC483a
each
Ask
OV8010a
Different stage of ovary cancer tissue array with metastasis carcinoma ( 2014 WHO classification) , including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores-OV8010a
each
Ask
MBS439549-01
Small Cell Lung Carcinoma Antigen (SCLC Marker) Mouse Monoclonal Antibody
0.02 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS439549-02
Small Cell Lung Carcinoma Antigen (SCLC Marker) Mouse Monoclonal Antibody
0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS439549-03
Small Cell Lung Carcinoma Antigen (SCLC Marker) Mouse Monoclonal Antibody
0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
MBS439549-04
Small Cell Lung Carcinoma Antigen (SCLC Marker) Mouse Monoclonal Antibody
5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
Ask
MBS439549-05
Small Cell Lung Carcinoma Antigen (SCLC Marker) Mouse Monoclonal Antibody
5x 0.1 mg (Without BSA & Azide at 1mg/mL)
Ask
UBD208a
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
64 Cases / 192 Cores
Ask
BR1005b
Breast cancer with matched metastatic carcinoma of lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BR1005a-BR1005b
each
Ask
LP208
High density larynx and pharynx squamous cell carcinoma and larynx and pharynx tissue array, including pathology grade, TNM and clinical stage, 69 cases/207 cores-LP208
each
Ask
ES902a
Esophagus squamous cell carcinoma with normal adjacent esophagus tissue array, including pathology grade and TNM/Stage, 45 cases/90 cores (core size 1.5mm), replacing ES902-ES902a
each
Ask
LC802c
Lung small cell carcinoma with lung tissue array, including IHC Synptophysin info, TNM/Stage (AJCC 8th edition), 40 cases/80 cores (core size 1.5mm), replacing LC802b-LC802c
each
Ask
LVN801
Normal liver and hepatocellular carcinoma (HCC) tissue array, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replacing BN03011-LVN801
each
Ask
BRM961a
Breast cancer with matched metastatic carcinoma or breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 49 cases/96 cores-BRM961a
each
Ask
CO242b
Colon carcinoma tissue array with adjacent normal colon tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing CO242a-CO242b
each
Ask
T421b
Small intestine carcinoma test tissue array, with normal small intestine tissues, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T421a-T421b
each
Ask
ES1922a
Esophagus squamous cell carcinoma with matched adjacent nomal esophagus tissue array, including TNM and pathology grade, 96 cases/ 192 cores ( core size 1.0mm)-ES1922a
each
Ask
LV8013a
Hepatocellular carcinoma (HCC) and normal tissue array, including pathology grade, TNM, stage, HBV and HCV infection information, 30 cases/80 cores, replaced by LV8013b-LV8013a
each
Ask
BR1008a
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
100 Cases / 100 Cores
Ask
Her2d
Her-2 IHC Bio-marker control tissue array of breast invasive ductal carcinoma, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores, replacing Her2c-Her2d
each
Ask
LC361
Lung large cell carcinoma with matched cancer adjacent lung tissue array, including TNM, clinical stage (AJCC 8.0) and IHC data (P63, TTF-1, CK7 and NSE), 13 casse/36 cores (2.0mm)-LC361
each
Ask
BL244b
Bladder invasive urothelial carcinoma with matched bladder tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores (1.5mm), replacing BL244a-BL244b
each
Ask
BR251f
Breast carcinoma with matched breast tissue array, including pathology grade, IHC info ( ER\PR\Her-2\Ki67), TNM\Sstage, 6 cases/24 cores ( core size 1.5mm), replacing BR251e-BR251f
each
Ask
OV812
Ovary primary carcinoma with matched metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 40 cases/80 cores-OV812
each
Ask
BC09022
Endometrial carcinoma tissue array with cancer adjacent tissue and adjacent normal tissue, including TNM, clinical stage and pathology grade, 67 cases/72 cores-BC09022
each
Ask
LC8010
Lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 80 cases/80 cores, replacing LC801-LC8010
each
Ask
OR301a
Lip squamous cell carcinoma tissue array with head and neck normal tissue, including pathology grade , TNM/Stage ( AJCC 7th edition), 30 cases/30 cores ( core size 2.0mm) , replacing OR301-OR301a
each
Ask
HN601d
Head and neck (nasal cavity, sinus, pharynx and larynx) squamous cell carcinoma tissue array, including pathology grade, P16 marker, TNM and clinical stage (AJCC 8.0), 60 cases/60 cores (1.5mm)-HN601d
each
Ask
LV487b
Hepatocellular carcinoma (HCC) tissue array with matched adjacent liver tissue, including TNM, pathology grade and clinical stage, 16 cases/48 cores ( core size 2.0mm), replacing LV487-LV487b
each
Ask
SK802c
Multiple sites of skin squamous cell carcinoma with skin tissue array, including pathology grade, TNM and clinical stage ( AJCC 7th edition), 80 cases/80 cores (core size 1.5mm) replacing SK802b-SK802c
each
Ask
MBS6002508-01
DACT1 (Dapper Homolog 1, hDPR1, Hepatocellular Carcinoma Novel Gene 3 Protein, DPR1, HNG3)
0.1 mg
Ask
MBS6002508-02
DACT1 (Dapper Homolog 1, hDPR1, Hepatocellular Carcinoma Novel Gene 3 Protein, DPR1, HNG3)
5x 0.1 mg
Ask
T104a
Cervix cancer tissue array, including squamous cell carcinoma, glassy cell carcinoma and adenocarcinoma, pathology grade, TNM and clinical stage, 6 cases/24 cores (1.5mm), replacing T104-T104a
each
Ask
ES1202
Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue array, including pathology grade, TNM and clinical stage, 60 cases/120 cores, replacing ES1201-ES1202
each
Ask
BR1008b
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result. 100 cases/100 cores, replacing BR1008a-BR1008b
each
Ask
LV8011b
Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a-LV8011b
each
Ask
LC953
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue , including TNM, clinical stage, pathology grade and survival data, 30 cases/95 cores, replacing LC952-LC953
each
Ask
OR208a
High density oral cavity squamous cell carcinoma and normal tissues array, including pathology grade, TNM and clinical stage (AJCC 8th edition), 69 cases/207 core, replacing OR208-OR208a
each
Ask
LC20815a
Multiple lung cancer tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma is referenced AJCC 8th version), 208 cases/208 cores, replacing LC20815-LC20815a
each
Ask
LP803
Larynx squamous cell carcinoma tissue array, including TNM/Stage (AJCC 8th edition), pathology grade and IHC (P16) . 80 cases/80 cores (core size 1.5mm), no overlapping with other TMAs (spectrum of disease)-LP803
each
Ask
BC04118a
Lung squamous cell carcinoma with matched lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing BC04118-BC04118a
each
Ask
ES2001b
Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue and metastatic carcinoma tissue array, including TNM and pathology grade, 120 cases/200 cores, replacing ES2001a-ES2001b
each
Ask
LC813b
Multiple lung cancer with lung tissue array, including pathology grade, TNM and clinical stage (small cell carcinoma and atypical carcinoid are referencing AJCC 8th version), 79 cases/80 cores, replacing LC813a-LC813b
each
Ask
MC485a
Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage (lung small cell carcinoma reference AJCC 8th version, others reference AJCC 7th version), 24 cores/48 cores, replacing MC485-MC485a
each
Ask
HER2c
Her-2 IHC Bio-marker control TMA, with breast invasive carcinoma of no special type, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki-67) results, 10 cases/10 cores, replacing Her2b
10 Cases / 10 Cores
Ask
KD603
Kidney cancer with matched adjacent normal kidney tissue array, containing metastatic clear cell carcinoma, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 33 cases/61 cores-KD603
each
Ask
PA721a
Pancreatic cancer tissue array with normal pancreatic tissue, including duct adenocarcinoma ( PADC) and islet cell carcinoma, TNM and pathology grade, 24 cases/96 cores ( core size 1.5mm), replacing PA721-PA721a
each
Ask
CO992b
Colorectal cancer with matched lymph node metastasis carcinoma and normal adjacent or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 43 cases/99 cores (1.5mm), replacing CO992a-CO992b
each
Ask
ES1505a
Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores ( core size 1.5mm), replacing ES1505-ES1505a
each
Ask
BS03013b
Hepatocellular carcinoma (HCC) with adjacent normal liver tissue array, including pathology grade, TNM and clinical stage, 23 cases/63 cores, replacing BS03013a, 12 cores may be missing after IHC, 50% discount-BS03013b
each
Ask
ES241a
Esophagus squamous cell carcinoma with matched adjacent normal esophagus tissue array, inclduing pathology grade, TNM and clinical stage (reference AJCC 7th version), 6 cases/24 cores, replacing ES241-ES241a
each
Ask
BC03118b
Intrahepatic cholangiocarcinoma, 70 hepatocellular carcinoma with liver tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 96 cases/192 cores, replacing BC03118-BC03118b
each
Ask
NE921
Multiple organ tumor with normal tissue array (20 cases neuroendocrine tumor) including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 46 cases/92 cores ( core size 1.5mm)-NE921
each
Ask
LC821
Lung cancer and lung tissue array with smoking history (2015 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 40 cases/80 cores-LC821
each
Ask
9-47041
Human Cancer PrimaCell™18: Thyroid Carcinoma Cells Growth Supplements with Serum (for 500 mL medium)
Set
Ask
LC10012b
Lung non-small cell carcinoma NSCLC tissue array with cancer adjacent lung tissue and normal lung tissue
each
Ask
MBS623534-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1)
0.2 mL
Ask
MBS623534-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1)
5x 0.2 mL
Ask
MBS6493278-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (AP)
0.2 mL
Ask
MBS6493278-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (AP)
5x 0.2 mL
Ask
MBS6493281-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (FITC)
0.2 mL
Ask
MBS6493281-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (FITC)
5x 0.2 mL
Ask
MBS6493282-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (Azide free) (HRP)
0.2 mL
Ask
MBS6493282-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (Azide free) (HRP)
5x 0.2 mL
Ask
MBS6493287-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 750)
0.1 mL
Ask
MBS6493287-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 750)
5x 0.1 mL
Ask
MBS6493288-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (PE)
0.2 mL
Ask
MBS6493288-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (PE)
5x 0.2 mL
Ask
MBS6493280-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (Biotin)
0.2 mL
Ask
MBS6493280-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (Biotin)
5x 0.2 mL
Ask
MBS6493285-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 550)
0.1 mL
Ask
MBS6493285-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 550)
5x 0.1 mL
Ask
MBS6006580-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53)
0.2 mL
Ask
MBS6006580-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53)
5x 0.2 mL
Ask
MBS6301562-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 550)
0.1 mL
Ask
MBS6301562-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 550)
5x 0.1 mL
Ask
MBS6301563-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 650)
0.1 mL
Ask
MBS6301563-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 650)
5x 0.1 mL
Ask
TH208a
Thyroid cancer with thyroid tissue array, including follicular thyroid carcinoma ( FTC), papillary thyroid carcinoma ( PTC), undifferentiated thyroid carcinoma ( ATC), TNM and clinical stage (AJCC 8.0), 69 cases/207 cores (1.0mm), replacing TH208-TH208a
each
Ask
GI961b
GI (esophagus, stomach, liver, small intestine, colon and rectum) carcinoma with normal tissue array, including pathology grade, TNM and clinical stage (stromal tumor reference AJCC 8th), 48 cases/96 cores, replacing GI961a-GI961b
each
Ask
CO1005a
Colon carcinoma, metastatic carcinoma and colon adenoma tissue array with colon tissue as control, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 98 cases/100 cores, replacing CO1005-CO1005a
each
Ask
BL243a
Bladder cancer with bladder tissue array, including urothelial carcinoma, squamous cell carcinoma, adenocarcinoma and normal tissue, pathololy grade, TNM and clinical stage (AJCC 8.0), 12 case/24 cores (1.5mm), replacing BL243-BL243a
each
Ask
MBS6301564-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 750)
0.1 mL
Ask
MBS6301564-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 750)
5x 0.1 mL
Ask
MBS6301565-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (PE)
0.2 mL
Ask
MBS6301565-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (PE)
5x 0.2 mL
Ask
MBS6301556-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (APC)
0.2 mL
Ask
MBS6301556-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (APC)
5x 0.2 mL
Ask
MBS6301557-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (Biotin)
0.2 mL
Ask
MBS6301557-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (Biotin)
5x 0.2 mL
Ask
MBS6301558-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (FITC)
0.2 mL
Ask
MBS6301558-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (FITC)
5x 0.2 mL
Ask
PA2082a
Pancreas cancer with pancreas tissue array, including ductal adenocarcinoma ( PADC) , acinar cell carcinoma ( PACC) , normal adjacent and pancreas tissue, pathology grade, TNM and clinical stage, 96 cases/192 cores ( 1.0mm), replacing PA2082-PA2082a
each
Ask
ES1505
Esophagus squamous cell carcinoma with matched cancer adjacent tissue and esophagus lymph node tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores ( core size 1.5mm), replaced by ES1505a-ES1505
each
Ask
BC04002b
Lung disease spectrum tissue with lung tissue array (2015 WHO classification), including pathology grade, TNM and clinical stage (small cell carcinoma reference AJCC 8th edition), 99 cases/100 cores, replacing BC04002a-BC04002b
each
Ask
MBS6493279-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (APC)
0.2 mL
Ask
MBS6493279-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (APC)
5x 0.2 mL
Ask
MBS6493283-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 405)
0.1 mL
Ask
MBS6493283-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 405)
5x 0.1 mL
Ask
MBS6493284-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 490)
0.1 mL
Ask
MBS6493284-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 490)
5x 0.1 mL
Ask
MBS6493286-01
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 650)
0.1 mL
Ask
MBS6493286-02
PLCL1, NT (Phospholipase C-related But Catalytically Inactive Protein, PRIP, Phospholipase C-deleted In Lung Carcinoma, Inactive Phospholipase C-like Protein 1, PLC-L1) (MaxLight 650)
5x 0.1 mL
Ask
MBS6301560-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 405)
0.1 mL
Ask
MBS6301560-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 405)
5x 0.1 mL
Ask
MBS6301561-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 490)
0.1 mL
Ask
MBS6301561-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (MaxLight 490)
5x 0.1 mL
Ask
MBS6301555-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (AP)
0.2 mL
Ask
MBS6301555-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (AP)
5x 0.2 mL
Ask
MBS6301559-01
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (Azide free) (H
0.2 mL
Ask
MBS6301559-02
GCC2, CT (GCC2, KIAA0336, RANBP2L4, GRIP and coiled-coil domain-containing protein 2, 185kD Golgi coiled-coil protein, CLL-associated antigen KW-11, CTCL tumor antigen se1-1, Ran-binding protein 2-like 4, Renal carcinoma antigen NY-REN-53) (Azide free) (H
5x 0.2 mL
Ask
MC401
Multiple organ tumor tissue array, including nasopharynx squamous cell carcinoma, stomach adenocarcinoma, colon adenocarcinoma, breast carcinoma, prostate adenocarcinoma, malignant melanoma, 7 types/40 cases/40 cores (1.5mm)-MC401
each
Ask
BC08032a
Breast invasive ductal carcinoma tissue array, with cancer adjacent breast tissue and adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 42 cases/63 cores ( core size 1.5mm) , replacing BC08032-BC08032a
each
Ask
LC2081
Non-small cell lung carcinoma NSCLC and normal tissue array, 70 cases/208 cores, with stage and grade information-LC2081
each
Ask
LV483a
Liver cancer and normal liver tissue array, including hepatocellular carcinoma, cholangiocellular carcinoma and normal tissues pathology grade, TNM and clinical stage (AJCC 7th edition), 48 cases/48 cores ( core size 1.5mm), replacing LV483-LV483a
each
Ask
HN802d
Multiple head and neck tumor with normal tissue array, including squamous cell carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, pathology grade, TNM and clinical stage (AJCC 8th edition), 80 cases/80 cores (core size 1.5mm), replacing HN802c-HN802d
each
Ask
MBS6151407-01
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP)
0.1 mL
Ask
MBS6151407-02
BCAS1 (Breast Carcinoma-amplified Sequence 1, Amplified and Overexpressed in Breast Cancer, Novel Amplified in Breast Cancer 1, AIBC1, NABC1) (HRP)
5x 0.1 mL
Ask
PA805c
Pancreas cancer with pancreas tissue array, including duct adenocarcinoma ( PDAC), acinar cell carcinoma ( PACC) , squamous cell carcinoma, normal adjacent pancreas and normal tissuepathology grade, TNM and clinical stage, 80 cases/80 cores ( 1.5mm), replacing PA805b-PA805c
each
Ask
OV1004a
Ovary cancer with ovary tissue array, including high grade serous carcinoma, mixed carcinoma and clear cell carcinoma, mucinous carcinoma, endometrioid carcinoma, pathology grade, TNM and clinical stage (AJCC 8.0), 50 cases/100 cores (core size 1.5mm), replacing OV1004-OV1004a
each
Ask
ES1041
Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma, adenocarcinoma, undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm) , replacing ES1021-ES1041
each
Ask
MBS6154566-01
RBM39 (HCC1, RNPC2, RNA-binding Protein 39, Hepatocellular Carcinoma Protein 1, RNA-binding Motif Protein 39, RNA-binding Region-containing Protein 2, Splicing Factor HCC1) (HRP)
0.1 mL
Ask
MBS6154566-02
RBM39 (HCC1, RNPC2, RNA-binding Protein 39, Hepatocellular Carcinoma Protein 1, RNA-binding Motif Protein 39, RNA-binding Region-containing Protein 2, Splicing Factor HCC1) (HRP)
5x 0.1 mL
Ask
MBS6392137-01
RBM39 (HCC1, RNPC2, RNA-binding Protein 39, Hepatocellular Carcinoma Protein 1, RNA-binding Motif Protein 39, RNA-binding Region-containing Protein 2, Splicing Factor HCC1) (HRP)
0.1 mL
Ask
MBS6392137-02
RBM39 (HCC1, RNPC2, RNA-binding Protein 39, Hepatocellular Carcinoma Protein 1, RNA-binding Motif Protein 39, RNA-binding Region-containing Protein 2, Splicing Factor HCC1) (HRP)
5x 0.1 mL
Ask
UT802a
Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802-UT802a
each
Ask
KD2001
Kidney tumour with normal tissue array, including Clear cell carcinoma (CCRCC), Sarcomatoid carcinoma, Papillary renal cell carcinoma (PRCC), Chromopobe carcinoma ( crcc), Invasive low grade urothelial carcinoma, with Isup Grade, TNM/Stage (AJCC 8th edition), 100 cases/200 cores (core size 1.0mm) , replacing BC07114-KD2001
each
Ask